Drug Shortage Report for UROMITEXAN
| Report ID | 214355 |
| Drug Identification Number | 02241411 |
| Brand name | UROMITEXAN |
| Common or Proper name | Mesna Injection |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | MESNA |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION |
| Route of administration | ORAL INTRAVENOUS ORAL INTRAVENOUS |
| Packaging size | 100 mg/mL, 10 mL, 15 units/case (2639B2010) |
| ATC code | V03AF |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-12-22 |
| Actual start date | 2023-12-22 |
| Estimated end date | 2024-02-23 |
| Actual end date | 2024-02-20 |
| Shortage status | Resolved |
| Updated date | 2024-02-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-02-21 | French | Compare |
| v5 | 2024-02-21 | English | Compare |
| v4 | 2024-01-16 | French | Compare |
| v3 | 2024-01-16 | English | Compare |
| v2 | 2023-12-27 | French | Compare |
| v1 | 2023-12-27 | English | Compare |
Showing 1 to 6 of 6